ROCKVILLE, Md.–(EMWNews)–Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company

will be presenting at the BMO Capital Markets “Focus

on Healthcare Conference” on Wednesday August

6, 2008 at 11:15 AM Eastern. A member of the company’s

senior management team will provide a corporate overview, including a

discussion of product development programs, recent corporate activities

and past financial performance.

A webcast of this presentation will be available both live and by

replay. To access either the live or archived webcast, please proceed to www.emergentbiosolutions.com,

and click on the “Investors”

link the day of the presentation.

An archived replay of the webcast will be available 24 hours after the

live presentation.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a leading biopharmaceutical company

dedicated to one simple mission—to protect

life. Emergent develops, manufactures and commercializes vaccines

and therapeutics that assist the body’s immune

system to prevent or treat disease. Emergent’s

products target infectious diseases and other medical conditions that

have resulted in significant unmet or underserved public health needs.

The company’s marketed product, BioThrax®

(Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S.

Food and Drug Administration for the prevention of anthrax infection. www.emergentbiosolutions.com.

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions